PMXSF
Pharmaxis Ltd

0
Loading...
Loading...
Syntara Ltd. is a clinical stage drug development company which engages in the development of healthcare products for haematological diseases. Its lead compounds include amsulostat (SNT-5055) and topical pan-LOX inhibitors with SNT-9495. The company was founded by Brett Charlton and William B. Cowden on May 29, 1998 and is headquartered in Sydney, Australia.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A

Frequently Asked Questions

Latest PMXSF News

View
No PMXSF news at the moment.

Advertisement|Remove ads.

Advertisement|Remove ads.